Coulter Partners announces top hires for VC & PE portfolio companies for Q4-2024

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function, Focus area, Location

• CEO, Antibody-based therapies, US

• CEO, Oncolytic viruses, UK

• CEO, Oncology biotech, Spain

• Chief Financial Officer, Nanotechnology diagnostics, Switzerland

• Chief Innovation Officer, Connected medical devices, France

• Chief R&D Officer, Gene-encoded drug discovery, UK

• Chief Commercial Officer, Computational chemistry, UK

• Chief Operating Officer, Outpatient services, Switzerland

• VP, Research & Preclinical, Synthetic biology, UK

• VP, Global Head of Sales, Omics platform, US

• VP, Marketing, Men’s health, UK

• Global Head of Regulatory Affairs, Anticoagulant technologies, UK

• Head of Global Distribution, Specialty pharma, France

• Program Director, Pharma software solutions, Belgium

• Managing Partner, Regulatory affairs consultancy, US

• Partner, Healthcare strategic communications, UK

• Chair, Cardiac devices, Israel

• Board Director, Specialty ingredients, UK

Newly opened projects include:

Function, Focus area, Location

• CEO, Exosome technologies, Italy

• Chief Scientific Officer, tRNA platform, US

• Chief Business Officer, 3D genome technologies, UK

• Chief Scientific Officer, Protein degraders, Italy

• Chief Development Officer, T-cell technologies, UK

• SVP, Clinical Operations, Cell therapies, US

• VP, Country General Manager, Contract Research Organization, Japan

• VP, Pharma Partnerships, Digital diagnostics, UK

• VP, Head of Early Discovery, Computational drug discovery, Denmark

• Global Head Toxicology Services, Laboratory & consulting services, Germany

• Head of Sales International, Medical lasers, Germany

• Head of Regulatory, Small molecule inhibitors, US

• Marketing & Business Development Lead, Biological & chemical sensors, France

• Country General Manager, Patient services, UK

• Board Director, Immunotherapies, Belgium

• Director of Venture Creation, University commercialization arm, UK